Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 2077 word(s) 2077 2021-07-12 08:34:52 |
2 Image added Meta information modification 2077 2021-09-10 08:31:01 | |
3 format correct + 357 word(s) 2434 2021-09-10 10:57:55 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Santhakumar, A. Bioaccessibility of Cereal Polyphenols. Encyclopedia. Available online: https://encyclopedia.pub/entry/14059 (accessed on 24 April 2024).
Santhakumar A. Bioaccessibility of Cereal Polyphenols. Encyclopedia. Available at: https://encyclopedia.pub/entry/14059. Accessed April 24, 2024.
Santhakumar, Abishek. "Bioaccessibility of Cereal Polyphenols" Encyclopedia, https://encyclopedia.pub/entry/14059 (accessed April 24, 2024).
Santhakumar, A. (2021, September 10). Bioaccessibility of Cereal Polyphenols. In Encyclopedia. https://encyclopedia.pub/entry/14059
Santhakumar, Abishek. "Bioaccessibility of Cereal Polyphenols." Encyclopedia. Web. 10 September, 2021.
Bioaccessibility of Cereal Polyphenols
Edit

Cereal bioactive compounds, especially polyphenols, are known to possess a wide range of disease preventive properties that are attributed to their antioxidant and anti-inflammatory activity. However, due to their low plasma concentrations after oral intake, there is controversy regarding their therapeutic benefits in vivo. Within the gastrointestinal tract, some cereal polyphenols are absorbed in the small intestine, with the majority accumulating and metabolised by the colonic microbiota.

cereal polyphenols bioaccessibility bioavailability microbiota intestinal barrier function inflammation oxidative stress

1. Introduction

Cereals such as wheat, rice, oats, barley and sorghum are grown and consumed as staple diets globally Cereals are edible seeds or grains of the grass family, Gramineae that have structural similarities: an outer bran layer, endosperm and embryo [1]. With the increase in chronic conditions such as obesity in developed countries and malnutrition in developing countries, cereal grains, due to their health benefits and affordability, provide nutritional value and food security, respectively. Substantial research has attributed the health benefits to bioactive compounds in whole grains, particularly micronutrients such as polyphenols.

Polyphenols are plant-based compounds (found in fruits, vegetables and grains) that have demonstrated bioactive properties including antithrombotic, anti-inflammatory and antioxidant properties both in vitro and in vivo [2][3][4][5]. They are a large group of heterogeneous compounds characterized by their basic structure consisting of a benzene ring with hydroxyl constituents [6]. For example, flavonoids, specific groups of polyphenols with A, B and C aromatic rings, exert antioxidant activity dependent on the functional groups attached and the degree of hydroxylation on the rings [7]. Among cereal grains, the phenolic composition may vary due to many factors such as environmental conditions, variety and pigmentation [8][9][10].

The coloured rice, rich in anthocyanin—the polyphenol responsible for pigmentation—also displayed strong antioxidant and anti-inflammatory activity in vitro and ex vivo [11]. Although studies in the past have attempted to investigate this interaction using polyphenols from various other food sources, an understanding of the role of cereal polyphenols is limited [12][13][14][15]. This review will provide an overview of the role of gastrointestinal (GI) digestion in the modulation of cereal polyphenol bioavailability. will be discussed by evaluating studies on dietary polyphenol bioaccessibility, the impact on intestinal barrier function, gut microbiome, and the associated antioxidant and anti-inflammatory plasma effects.

2. Cereal Polyphenols

The common phenolic compounds found in cereals include flavonoids and phenolic acids, classified as hydroxybenzoic or hydroxycinnamic acids [9]. Hydroxybenzoic and hydroxycinnamic acids possess free radical scavenging ability due to their polarity and hydroxyl groups (Table 1). One of the most abundant phenolic acids in cereals, ferulic acid, has one hydrogen atom from its hydroxyl group that can react with a free radical to exhibit antioxidant activity [9]. Other phenolic acids such as protocatechuic acid and caffeic

Table 1. Basic structures of common phenolic compounds found in cereals.
Hydroxybenzoic acid Hydroxycinnamic acid
Foods 10 01595 i001
Gallic acid: R1 = OH; R2 = OH; R3 = OH
Protocatechuic acid: R1 = OH; R2 = OH; R3 = H
Vanillic acid: R1 = OH; R2 = OCH3; R3 = H
Hydrobenzoic acid: R1 = H; R2 = OH; R3 = H
Foods 10 01595 i002
Caffeic acid: R1 = OH; R2 = OH
Ferulic acid: R1 = OCH3; R2 = OH
p-coumaric acid: R1 = H; R2 = OH
Flavonoid backbone Flavonol
Foods 10 01595 i003
Flavanones: C4 keto group
Flavanols: C4 keto group, C3 hydroxyl group
Flavones: C2–C3 double bond, C4 keto group
Flavan-3-ols: C3-hydroxyl group
Foods 10 01595 i004
Quercetin: R1 = OH
Rutin (quercetin 3-O glucoside): R1 = O-β-D-rutinoside
Anthocyanin 3-Deoxyanthocyanidin
Foods 10 01595 i005
Cyanidin 3-glucoside: R1 = OH; R2 = OH; R3 = H; R4 = O-β-D-glucoside
Delphinidin 3-glucoside: R1 = OH; R2 = OH; R3 = OH; R4 = O-β-D-glucoside
Peonidin 3-glucoside: R1 = OCH3; R2 = OH; R3 = H; R4 = O-β-D-glucoside
Petunidin 3-glucoside: R1 = OH; R2 = OH; R3 = OCH3; R4 = O-β-D-glucoside
Malvidin 3-glucoside: R1 = OCH3; R2 = OH; R3 = OCH3; R4 = O-β-D-glucoside
Pelargonidin 3-glucoside: R1 = H; R2 = OH; R3 = H; R4 = O-β-D-glucoside
Foods 10 01595 i006
Apigeninidin: R1 = H
Luteolinidin: R1 = OH
Avenanthramide Tannin repeating unit
Foods 10 01595 i007
AVN A: R1 = H
AVN B: R1 = OCH3
AVN C: R1 = OH
Foods 10 01595 i008
Catechin (or epicatechin) basic repeating unit: R1 = H
Proanthocyanidin (or Procyanidin): R1 = Catechin

Flavonoids contain functional groups that enhance both antioxidant and anti-inflammatory activity [16]. Flavones such as apigenin possess the 2,3-double bond and 4-keto group of the C ring that contribute to their antioxidant and anti-inflammatory activity and enhance affinity to target protein receptors [16]. but with low bioavailability (1–100 nmol/L of total anthocyanin plasma concentration following doses of 0.7–10.9 mg/kg in human studies) However, most of these structure–activity studies on cereal polyphenols have been undertaken in vitro and thus may not reflect the bioactivity observed in vivo especially after cereals undergo GI digestion.

Cereal grains when ingested travel first through the GI tract before being metabolised further by the liver and then entering the systemic circulation (Figure 1). The polyphenol-containing bolus then travels to the stomach where it undergoes gastric digestion involving gastric juice containing hydrochloric acid, pepsin, lipase, mucus, electrolytes and water [17]. Some polymeric polyphenols such as procyanidins can be degraded into smaller units during gastric digestion, but there is limited information on the impact gastric digestion has on the bioactivity of cereal polyphenols [18]. Evaluation of the structure–activity relationship of mono- and di-glucosyl anthocyanins reveals that they are better ligands for the bili-translocase than their corresponding aglycones [19].

Figure 1. Schematic illustration of the impact of GI digestion in modulating bioavailability of cereal polyphenols. Cereal polyphenols travel through the digestive tract post-ingestion and the majority accumulate in the gut. (1) The cereal matrix forms a bolus and enhances the solubility of hydrophobic polyphenols. (2) Phenolic compounds such as anthocyanin glycosides can be absorbed quickly at the gastric phase. (3) In the small intestine, low molecular weight phenolic compounds are absorbed through active transport or sodium-dependent glucose transport. The first pass metabolism of polyphenols begins in the enterocytes and liver phenolic metabolites return to the intestines via the bile duct excretion. (4) The majority of polyphenols including polymeric compounds and phenolic acids bound to fibre are metabolised in the colon into smaller molecular weight forms that are bioaccessible. (5) Phenolic metabolites in the plasma are transported either freely or bound to blood proteins such as albumin to exert bioactivity in surrounding cells or tissues. (6) Phenolic metabolites are excreted in faeces or urine via the gut or blood, respectively. The figure was created with BioRender.com.

In the small intestines, the digesta from the stomach is neutralised by sodium hydroxide allowing intestinal enzymes to catabolize the food matrix [20]. However, it is postulated that, due to the hydrophilic nature of some glycosylated flavonols and derivatives of hydro-cinnamic acid, they may be readily soluble in the aqueous environment, whereas less soluble phenolic compounds such as flavonoid aglycones or procyanidins are bound to dietary fibre and proteins [17]. The stability of the phenolic compounds has been attributed mainly to the pH, with some phenolic compounds being degraded through non-enzymatic oxidisation. The discrepancy in the quantification of anthocyanins is due to the pH-dependent equilibrium of the flavylium cation form to other related structural forms above pH 2 [21].

It is unclear what specific transport mechanisms are involved in polyphenol intestinal absorption. For monomeric compounds such as cinnamic acid and ferulic acid, a Na+ dependent transport mechanism has been postulated [22][23]. However, anthocyanins such as cyanidin 3-glucosides (C3G) are not substrates to either CBG or LPH but their absorption may be competitively inhibited by the presence of other flavonoids [21][24]. Nonetheless, the lack of enzymatic degradation of some polyphenols as well as their interaction with other dietary antioxidants in the cereal matrix may allow them to accumulate in the colon and exert bioactive functions therein [25].

Polymeric or oligomeric compounds such as pro-anthocyanidins, due to their high molecular weight, are unlikely to be absorbed in the small intestine, but pass through to the colon [24]. Dietary fibres such as xylose, cellulose, β-glucans, and arabinoxylans that are bound to polyphenols are substrates of microbial catabolism resulting in the production of short-chain fatty acids and the release of polyphenols for absorption [26]. Ferulic acid, found in the bran and aleurone layer of cereals, is usually bound to arabinoxylans and can be released by hydrolysis of ester linkages [27]. The absorption in the intestines is due to the size or number of sugar moieties such as arabinose and xylose.

The pathway of metabolism for polyphenols is similar to xenobiotics (substances foreign to the body such as environmental chemicals and drugs) and thus involves extensive metabolism to counteract any potential toxic effects [28]. During the first pass metabolism of polyphenols, three main conjugations occur in the small intestine and the liver—glucuronidation, sulfation and methylation [29][30]. Interestingly, sulphate and glucuronate metabolites of ferulic acid and caffeic acid have been shown to retain their strong bioactivity when compared to their parent compounds [31]. This highlights the possibility of cereal phenolic metabolites to retain strong bioactivity locally in the gut and systemically in plasma.

This warrants confirmation by investigating polyphenolic binding affinity using improved detection and measurement tools. Examination of urinary and faecal excretion demonstrates that cereal consumption results in lower molecular weight phenolic compounds such as ferulic acid, dihydro-ferulic acid, hippuric acid, and hydroxy-hippuric acid [32][33]. These phenolic compounds may result from the absorption of compounds from the small intestine via colonic catabolism of polymeric compounds, or release compounds bound to the cereal fibre. The impact of the phenolic compounds on the intestinal environment is particularly important as the compounds metabolised in the liver return to the small intestines via the bile duct in a pathway known as enterohepatic recirculation resulting in more exposure to bio-transformed polyphenols [34]

3. Polyphenol Bioaccessibility in the GI Tract

The GI tract plays a key role in modulating the bioaccessibility and subsequent bioavailability of polyphenols in vivo. However, inter-individual variation creates challenges in analysing bioaccessibility and, thus, an in vitro GI digestion model provides a more standardised approach in analysis [35][36]. To determine the recovery of polyphenols post GI digestion, two common models used are small intestine bioaccessibility large intestine bioaccessibility. The former focuses on the amount and type of polyphenols that are absorbed and transported across the small intestine and other upper GI organs whereas the latter focuses on the polyphenols and metabolites absorbed and transported after microbial metabolism in the colon.

Results indicated that date seed powder and extract recovered more phenolic compounds than the bread form. Furthermore, it was observed that the phenolic compounds increased as digestion progressed (vanillic acid recorded 91% and 89% recovery following digestion of the powder and extract form). This observation agreed with the study by Chandrasekara and Shahidi [37] which demonstrated that total phenolic content increased during in vitro GI digestion of cooked millet grains. [38] that demonstrated an increase in phenolic acids and flavonoids but a significant reduction in antioxidant activity after digestion of different apple varieties.

Interestingly, anthocyanins and phenolic acids in purple rice phenolic extracts have been shown to exhibit antioxidant and anti-inflammatory effects in vitro [39]. [40] demonstrated that, among the polyphenols recovered, phenolic acids were the predominant compounds transported across a Caco-2 cell monolayer. In comparison, a cross-over dietary intervention trial employing the same three forms of the same date seeds observed significant antioxidant effects in blood in conjunction with an abundant release of polyphenol metabolites including simple phenolic acids in the urine [41]. Together, these studies display the potential of bioaccessibility models to predict in vivo bioavailability of polyphenols.

The cereal grains with higher fibre content displayed lower bioaccessibility levels of polyphenols indicating the ineffectiveness of digestive enzymes in releasing conjugated polyphenols when compared to microbial enzymes (Table 2). It should be noted that there is a lack of a standardised approach to measuring bioaccessibility and predicting polyphenol bioavailability. However, the bioaccessibility of polyphenols post-digestion can be reduced significantly, and consequently in vivo bioactivity may be attributed to the metabolites present. Since cereal polyphenols travel to the colon during digestion, it will be of interest to investigate the impact of simulated GI digestion on the bioactive properties of the polyphenols and their potential impact on gut health.

4. Cereal Polyphenol Impact on the Gut Microbiome and Plasma Anti-Inflammatory Status

Gut microbiota is a regulator of intestinal and systemic health that is gaining much attention due to its multifaceted role in modulating host immune response and metabolism [42][43]. These bacterial communities maintain intestinal barrier integrity by detoxifying xenobiotics, competing with pathogenic bacteria and keeping the mucosal immune system active [44][45]. The composition of the microbiome can be altered by factors including age, delivery pattern, drugs and diet [46]. Metformin, a drug that regulates systemic metabolism by reducing blood glucose, has been shown to alter the gut microbiota composition, thereby suggesting the gut microbiome as a possible signalling pathway for the drug to exerts its physiological functions [47].

There is growing interest in understanding polyphenol interactions with gut microbiota as a key link to explain the health benefits observed in metabolic diseases [48]. [49] using an in vitro fermentation model of the gut microbiota showed that the whole oat bran, rather than its main bioactive polyphenols, induced an increase in Bifidobacteriumand short-chain fatty acids. These metabolites coupled with the parent compound AVN were shown in the study to induce apoptosis in colon cancer cells thus potentially promoting gut health. This presents an interesting area of research into clarifying mechanisms by which oat bran polyphenols mediate systemic effects by interacting with the gut microbiome in vivo.

[50] demonstrated that red rice bran polyphenols increased the relative abundance of Faecalibacterium—beneficial bacteria producing butyrate. In the study, however, combined supplementation of ferulyated arabinoxylan oligosaccharides and rice bran phenolic extracts exerted a stronger prebiotic effect—that is, an increased abundance of butyrogenic bacteria, namelyCoproccusandRoseburi. Results demonstrated that Sumac and Black sorghum bran polyphenols independently stimulated the growth ofRoseburiaandPrevotellabut worked together with a prebiotic, fructo-oligosaccharide to promote the growth ofBifidobacteriumandLactobacillus. Furthermore, pro-anthocyanidins are converted by the gut microbiota into lower molecular weight phenolic acids which may have bioactive relevance in vivo [51].

Some trials have indicated a reduction in systemic inflammation but no significant change on gut microbiota when consuming whole grains as opposed to refined grains [34][52][53]. [54] demonstrated that after obese and overweight participants consumed whole grain there was a significant reduction in serum inflammatory markers but no significant change in the gut microbiome. [33] observed a beneficial impact on the gut microbiome, wherein whole grain consumption significantly increased beneficial bacteria (BacteroidesandLactobacillus) and decreased inflammatory bacteriaEnterobacteriaceae. Results indicated significant increases in serum phenolic metabolites after whole grain consumption which was associated with a significant reduction in TNF-α and IL-10. Reduction in TNF-α levels correlated with increased abundance of beneficial bacteria, thus highlighting a plausible association between microbiome modulation and plasma inflammatory status that needs further investigation.

Pigmented whole grain varieties have shown significant anti-inflammatory effects that can be attributed to their anthocyanin content. However, only modest differences were observed between the inflammatory status of participants consuming purple wheat and regular wheat. Nevertheless, C3G-rich black rice has demonstrated therapeutic benefits by reducing C reactive protein (CRP) in coronary heart disease patients when consumed long term [55]. Purple rice and red rice have also demonstrated anti-inflammatory effects (reduction in IL-6, IL-10 and IL-12) and reduction in lipid peroxidation

References

  1. McKevith, B. Nutritional aspects of cereals. Nutr. Bull. 2004, 29, 111–142.
  2. Stainer, A.R.; Sasikumar, P.; Bye, A.P.; Unsworth, A.J.; Holbrook, L.M.; Tindall, M.; Lovegrove, J.A.; Gibbins, J.M. The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects. TH Open 2019, 3, e244–e258.
  3. Francis, N.; Rao, S.; Blanchard, C.; Santhakumar, A. Black Sorghum Phenolic Extract Regulates Expression of Genes Associated with Oxidative Stress and Inflammation in Human Endothelial Cells. Molecules 2019, 24, 3321.
  4. Santhakumar, A.B.; Bulmer, A.C.; Singh, I. A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk. J. Hum. Nutr. Diet. 2014, 27, 1–21.
  5. Thompson, K.; Hosking, H.; Pederick, W.; Singh, I.; Santhakumar, A. The effect of anthocyanin supplementation in modulating platelet function in sedentary population: A randomised, double-blind, placebo-controlled, cross-over trial. Br. J. Nutr. 2017, 118, 368–374.
  6. Santhakumar, A.B.; Battino, M.; Alvarez-Suarez, J.M. Dietary polyphenols: Structures, bioavailability and protective effects against atherosclerosis. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2018, 113, 49–65.
  7. Lin, C.-Z.; Zhu, C.-C.; Hu, M.; Wu, A.-Z.; Bairu, Z.-D.; Kangsa, S.-Q. Structure-activity relationships of antioxidant activity in vitro about flavonoids isolated from Pyrethrum tatsienense. J. Intercult. Ethnopharmacol. 2014, 3, 123–127.
  8. Rao, S.; Santhakumar, A.B.; Chinkwo, K.A.; Wu, G.; Johnson, S.K.; Blanchard, C.L. Characterization of phenolic compounds and antioxidant activity in sorghum grains. J. Cereal Sci. 2018, 84, 103–111.
  9. Rao, S.; Schwarz, L.J.; Santhakumar, A.B.; Chinkwo, K.A.; Blanchard, C.L. Cereal phenolic contents as affected by variety and environment. Cereal Chem. 2018, 95, 589–602.
  10. Wu, G.; Johnson, S.K.; Bornman, J.F.; Bennett, S.J.; Fang, Z. Changes in whole grain polyphenols and antioxidant activity of six sorghum genotypes under different irrigation treatments. Food Chem. 2017, 214, 199–207.
  11. Callcott, E.T.; Santhakumar, A.B.; Strappe, P.; Luo, J.; Blanchard, C.L. Polyphenols from Australian-grown pigmented red and purple rice inhibit adipocyte differentiation. J. Cereal Sci. 2018, 81, 140–146.
  12. Bianchi, M.G.; Chiu, M.; Taurino, G.; Brighenti, F.; Del Rio, D.; Mena, P.; Bussolati, O. Catechin and Procyanidin B(2) Modulate the Expression of Tight Junction Proteins but Do Not Protect from Inflammation-Induced Changes in Permeability in Human Intestinal Cell Monolayers. Nutrients 2019, 11, 2271.
  13. Wang, K.; Jin, X.; Chen, Y.; Song, Z.; Jiang, X.; Hu, F.; Conlon, M.A.; Topping, D.L. Polyphenol-Rich Propolis Extracts Strengthen Intestinal Barrier Function by Activating AMPK and ERK Signaling. Nutrients 2016, 8, 272.
  14. Wu, B.; Li, S.; Chang, H.; Anderson, R.; Chopra, S.; Reddivari, L. Maize Flavan-4-ols and Anthocyanins Alleviated Dextran Sulfate Sodium-Induced Colitis in Mice via Intestinal Barrier Function Restoration. Curr. Dev. Nutr. 2020, 4, 488.
  15. Biasi, F.; Guina, T.; Maina, M.; Cabboi, B.; Deiana, M.; Tuberoso, C.I.; Calfapietra, S.; Chiarpotto, E.; Sottero, B.; Gamba, P.; et al. Phenolic compounds present in Sardinian wine extracts protect against the production of inflammatory cytokines induced by oxysterols in CaCo-2 human enterocyte-like cells. Biochem. Pharmacol. 2013, 86, 138–145.
  16. Awika, J.M.; Rose, D.J.; Simsek, S. Complementary effects of cereal and pulse polyphenols and dietary fiber on chronic inflammation and gut health. Food Funct. 2018, 9, 1389–1409.
  17. Alminger, M.; Aura, A.-M.; Bohn, T.; Dufour, C.; El, S.N.; Gomes, A.; Karakaya, S.; Martínez-Cuesta, M.C.; McDougall, G.J.; Requena, T.; et al. In Vitro Models for Studying Secondary Plant Metabolite Digestion and Bioaccessibility. Compr. Rev. Food Sci. Food Saf. 2014, 13, 413–436.
  18. Spencer, J.P.; Chaudry, F.; Pannala, A.S.; Srai, S.K.; Debnam, E.; Rice-Evans, C. Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun. 2000, 272, 236–241.
  19. Passamonti, S.; Vrhovsek, U.; Mattivi, F. The interaction of anthocyanins with bilitranslocase. Biochem. Biophys. Res. Commun. 2002, 296, 631–636.
  20. Wojtunik-Kulesza, K.; Oniszczuk, A.; Oniszczuk, T.; Combrzyński, M.; Nowakowska, D.; Matwijczuk, A. Influence of In Vitro Digestion on Composition, Bioaccessibility and Antioxidant Activity of Food Polyphenols-A Non-Systematic Review. Nutrients 2020, 12, 1401.
  21. Fang, J. Bioavailability of anthocyanins. Drug Metab. Rev. 2014, 46, 508–520.
  22. Ader, P.; Grenacher, B.; Langguth, P.; Scharrer, E.; Wolffram, S. Cinnamate uptake by rat small intestine: Transport kinetics and transepithelial transfer. Exp. Physiol. 1996, 81, 943–955.
  23. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S–242S.
  24. Walton, M.C.; McGhie, T.K.; Reynolds, G.W.; Hendriks, W.H. The flavonol quercetin-3-glucoside inhibits cyanidin-3-glucoside absorption in vitro. J. Agric. Food Chem. 2006, 54, 4913–4920.
  25. Kamiloglu, S.; Tomas, M.; Ozdal, T.; Capanoglu, E. Effect of food matrix on the content and bioavailability of flavonoids. Trends Food Sci. Technol. 2020.
  26. Călinoiu, L.F.; Vodnar, D.C. Whole Grains and Phenolic Acids: A Review on Bioactivity, Functionality, Health Benefits and Bioavailability. Nutrients 2018, 10, 1615.
  27. Mateo Anson, N.; van den Berg, R.; Havenaar, R.; Bast, A.; Haenen, G.R.M.M. Bioavailability of ferulic acid is determined by its bioaccessibility. J. Cereal Sci. 2009, 49, 296–300.
  28. D’Archivio, M.; Filesi, C.; Varì, R.; Scazzocchio, B.; Masella, R. Bioavailability of the polyphenols: Status and controversies. Int. J. Mol. Sci. 2010, 11, 1321–1342.
  29. Boersma, M.G.; van der Woude, H.; Bogaards, J.; Boeren, S.; Vervoort, J.; Cnubben, N.H.; van Iersel, M.L.; van Bladeren, P.J.; Rietjens, I.M. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 2002, 15, 662–670.
  30. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747.
  31. Piazzon, A.; Vrhovsek, U.; Masuero, D.; Mattivi, F.; Mandoj, F.; Nardini, M. Antioxidant Activity of Phenolic Acids and Their Metabolites: Synthesis and Antioxidant Properties of the Sulfate Derivatives of Ferulic and Caffeic Acids and of the Acyl Glucuronide of Ferulic Acid. J. Agric. Food Chem. 2012, 60, 12312–12323.
  32. Price, R.K.; Welch, R.W.; Lee-Manion, A.M.; Bradbury, I.; Strain, J.J. Total Phenolics and Antioxidant Potential in Plasma and Urine of Humans after Consumption of Wheat Bran. Cereal Chem. 2008, 85, 152–157.
  33. Vitaglione, P.; Mennella, I.; Ferracane, R.; Rivellese, A.A.; Giacco, R.; Ercolini, D.; Gibbons, S.M.; La Storia, A.; Gilbert, J.A.; Jonnalagadda, S.; et al. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: Role of polyphenols bound to cereal dietary fiber. Am. J. Clin. Nutr. 2015, 101, 251–261.
  34. Anhê, F.F.; Varin, T.V.; Le Barz, M.; Pilon, G.; Dudonné, S.; Trottier, J.; St-Pierre, P.; Harris, C.S.; Lucas, M.; Lemire, M.; et al. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice. Diabetologia 2018, 61, 919–931.
  35. Carbonell-Capella, J.M.; Buniowska, M.; Barba, F.J.; Esteve, M.J.; Frígola, A. Analytical Methods for Determining Bioavailability and Bioaccessibility of Bioactive Compounds from Fruits and Vegetables: A Review. Compr. Rev. Food Sci. Food Saf. 2014, 13, 155–171.
  36. Brodkorb, A.; Egger, L.; Alminger, M.; Alvito, P.; Assunção, R.; Ballance, S.; Bohn, T.; Bourlieu-Lacanal, C.; Boutrou, R.; Carrière, F.; et al. INFOGEST static in vitro simulation of gastrointestinal food digestion. Nat. Protoc. 2019, 14, 991–1014.
  37. Chandrasekara, A.; Shahidi, F. Bioaccessibility and antioxidant potential of millet grain phenolics as affected by simulated in vitro digestion and microbial fermentation. J. Funct. Foods 2012, 4, 226–237.
  38. Bouayed, J.; Hoffmann, L.; Bohn, T. Total phenolics, flavonoids, anthocyanins and antioxidant activity following simulated gastro-intestinal digestion and dialysis of apple varieties: Bioaccessibility and potential uptake. Food Chem. 2011, 128, 14–21.
  39. Callcott, E.T.; Blanchard, C.L.; Snell, P.; Santhakumar, A.B. The anti-inflammatory and antioxidant effects of pigmented rice consumption in an obese cohort. Food Funct. 2019, 10, 8016–8025.
  40. Hilary, S.; Tomás-Barberán, F.A.; Martinez-Blazquez, J.A.; Kizhakkayil, J.; Souka, U.; Al-Hammadi, S.; Habib, H.; Ibrahim, W.; Platat, C. Polyphenol characterisation of Phoenix dactylifera L. (date) seeds using HPLC-mass spectrometry and its bioaccessibility using simulated in-vitro digestion/Caco-2 culture model. Food Chem. 2020, 311, 125969.
  41. Platat, C.; Hillary, S.; Tomas-Barberan, F.A.; Martinez-Blazquez, J.A.; Al-Meqbali, F.; Souka, U.; Al-Hammadi, S.; Ibrahim, W. Urine Metabolites and Antioxidant Effect after Oral Intake of Date (Phoenix dactylifera L.) Seeds-Based Products (Powder, Bread and Extract) by Human. Nutrients 2019, 11, 2489.
  42. Zhang, Z.; Tang, H.; Chen, P.; Xie, H.; Tao, Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct. Target. Ther. 2019, 4, 41.
  43. Guinane, C.M.; Cotter, P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Ther. Adv. Gastroenterol. 2013, 6, 295–308.
  44. Hiippala, K.; Jouhten, H.; Ronkainen, A.; Hartikainen, A.; Kainulainen, V.; Jalanka, J.; Satokari, R. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018, 10, 988.
  45. Lu, K.; Mahbub, R.; Fox, J.G. Xenobiotics: Interaction with the Intestinal Microflora. ILAR J. 2015, 56, 218–227.
  46. Hasan, N.; Yang, H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 2019, 7, e7502.
  47. Ma, W.; Chen, J.; Meng, Y.; Yang, J.; Cui, Q.; Zhou, Y. Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis. Front. Microbiol. 2018, 9, 1336.
  48. Corrêa, T.A.F.; Rogero, M.M.; Hassimotto, N.M.A.; Lajolo, F.M. The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. Front. Nutr. 2019, 6, 188.
  49. Kristek, A.; Wiese, M.; Heuer, P.; Kosik, O.; Schär, M.Y.; Soycan, G.; Alsharif, S.; Kuhnle, G.G.C.; Walton, G.; Spencer, J.P.E. Oat bran, but not its isolated bioactive β-glucans or polyphenols, have a bifidogenic effect in an in vitro fermentation model of the gut microbiota. Br. J. Nutr. 2019, 121, 549–559.
  50. Pham, T.; Teoh, K.T.; Savary, B.J.; Chen, M.-H.; McClung, A.; Lee, S.-O. In Vitro Fermentation Patterns of Rice Bran Components by Human Gut Microbiota. Nutrients 2017, 9, 1237.
  51. Déprez, S.p.; Brezillon, C.; Rabot, S.; Philippe, C.; Mila, I.; Lapierre, C.; Scalbert, A. Polymeric Proanthocyanidins Are Catabolized by Human Colonic Microflora into Low-Molecular-Weight Phenolic Acids. J. Nutr. 2000, 130, 2733–2738.
  52. Roopchand, D.E.; Carmody, R.N.; Kuhn, P.; Moskal, K.; Rojas-Silva, P.; Turnbaugh, P.J.; Raskin, I. Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. Diabetes 2015, 64, 2847–2858.
  53. Kuhn, P.; Kalariya, H.M.; Poulev, A.; Ribnicky, D.M.; Jaja-Chimedza, A.; Roopchand, D.E.; Raskin, I. Grape polyphenols reduce gut-localized reactive oxygen species associated with the development of metabolic syndrome in mice. PLoS ONE 2018, 13, e0198716.
  54. Kopf, J.C.; Suhr, M.J.; Clarke, J.; Eyun, S.I.; Riethoven, J.M.; Ramer-Tait, A.E.; Rose, D.J. Role of whole grains versus fruits and vegetables in reducing subclinical inflammation and promoting gastrointestinal health in individuals affected by overweight and obesity: A randomized controlled trial. Nutr. J. 2018, 17, 72.
  55. Wang, Q.; Han, P.; Zhang, M.; Xia, M.; Zhu, H.; Ma, J.; Hou, M.; Tang, Z.; Ling, W. Supplementation of black rice pigment fraction improves antioxidant and anti-inflammatory status in patients with coronary heart disease. Asia Pac. J. Clin. Nutr. 2007, 16 (Suppl. 1), 295–301.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 425
Revisions: 3 times (View History)
Update Date: 10 Sep 2021
1000/1000